Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

What is Genetic Engineering?00:49

What is Genetic Engineering?

73.7K
Overview
73.7K
Gene Therapy00:59

Gene Therapy

25.2K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.2K
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

13.8K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
13.8K
Plant Breeding and Biotechnology01:59

Plant Breeding and Biotechnology

18.8K
Crop cultivation has a long history in human civilization, with records showing the cultivation of cereal plants beginning at around 8000 BC. This early plant breeding was developed primarily to provide a steady supply of food.
18.8K
Genetic Lingo01:11

Genetic Lingo

101.2K
Overview
101.2K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Outcomes of Ab Interno 63 µm vs. 45 µm XEN<sup>®</sup> Gel Stent in Open-Angle Glaucoma: A Five-Year Follow-Up Study.

Journal of clinical medicine·2026
Same author

Blood flow patterns in mice are regulated by interpericyte tunneling nanotubes connecting functionally-opposite neuronal areas.

Nature communications·2026
Same author

A Systematic Review of Current Terminology for Conditions Preceding Degenerative Cervical Myelopathy: Evidence Synthesis to Inform an AO Spine Expert Opinion Statement.

Global spine journal·2025
Same author

Potential Retinal Biomarkers in Alzheimer's Disease.

International journal of molecular sciences·2023
Same author

Immunobiology of a rationally-designed AAV2 capsid following intravitreal delivery in mice.

Gene therapy·2023
Same author

A scoping review of information provided within degenerative cervical myelopathy education resources: Towards enhancing shared decision making.

PloS one·2022
Same journal

Determinants of regression kinetics in observed stage 3 retinopathy of prematurity without plus disease.

Eye (London, England)·2026
Same journal

Oculomics and the NHS: A UK opportunity to translate eye-derived biomarkers into population health.

Eye (London, England)·2026
Same journal

Long-term follow-up and outcomes of a Diabetic Eye Screening Programme in patients aged 80 with no diabetic eye disease at baseline: should we be routinely screening this cohort?

Eye (London, England)·2026
Same journal

Real world experience with faricimab in switched neovascular AMD and evaluation of reloading versus interval matching regimes.

Eye (London, England)·2026
Same journal

"When the lens drew a continent: a cartographic clue to Alport syndrome".

Eye (London, England)·2026
Same journal

Infographic: efficacy and safety of teprotumumab in patients with thyroid eye disease of long duration and low disease activity.

Eye (London, England)·2026
查看所有相关文章

相关实验视频

Updated: Jun 8, 2025

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
07:04

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System

Published on: February 4, 2021

2.0K

基因工程和眼睛

Rory Murphy1,2, Keith R Martin3,4

  • 1Department of Ophthalmology, Royal Victoria Eye and Ear Hospital, Dublin, Ireland.

Eye (London, England)
|November 8, 2024
PubMed
概括
此摘要是机器生成的。

基因工程为盲目的眼睛疾病提供了革命性的治疗方法. 基因编辑工具和传递系统的进步为未来的视力恢复策略铺平了道路.

更多相关视频

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye
05:09

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye

Published on: November 25, 2012

33.1K
Isolation, Culture, and Genetic Engineering of Mammalian Primary Pigment Epithelial Cells for Non-Viral Gene Therapy
09:46

Isolation, Culture, and Genetic Engineering of Mammalian Primary Pigment Epithelial Cells for Non-Viral Gene Therapy

Published on: February 26, 2021

3.2K

相关实验视频

Last Updated: Jun 8, 2025

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System
07:04

Electroporation-Based Genetic Modification of Primary Human Pigment Epithelial Cells Using the Sleeping Beauty Transposon System

Published on: February 4, 2021

2.0K
Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye
05:09

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye

Published on: November 25, 2012

33.1K
Isolation, Culture, and Genetic Engineering of Mammalian Primary Pigment Epithelial Cells for Non-Viral Gene Therapy
09:46

Isolation, Culture, and Genetic Engineering of Mammalian Primary Pigment Epithelial Cells for Non-Viral Gene Therapy

Published on: February 26, 2021

3.2K

科学领域:

  • 眼科医生 眼科 眼科
  • 遗传学 遗传学是一种遗传学.
  • 分子生物学分子生物学

背景情况:

  • 眼睛是基因工程的理想目标,因为它具有免疫特权和可访问性.
  • 最近基因编辑技术的进步加速了眼部基因治疗的进展.

研究的目的:

  • 为了回顾眼睛基因工程的最新进展.
  • 检查这些技术的当前治疗应用.
  • 探索视力恢复的未来策略.

主要方法:

  • 使用先进的基因编辑工具,如CRISPR/Cas9,基因编辑器,主要编辑器和转基因酶.
  • 开发新的传递系统,包括病毒和非病毒载体.
  • 探索新的策略,如体内细胞重编程和光遗传学.

主要成果:

  • 现在可以在眼睛组织中实现高效和特定的基因修饰.
  • 传递系统和遗传工具的进步提高了眼部基因治疗的疗效.
  • 新兴的策略显示神经保护和神经再生在眼睛的承诺.

结论:

  • 眼部基因工程在治疗致盲疾病方面具有显著的潜力.
  • 基因编辑和传递系统的持续创新将推动未来的治疗进展.
  • 这些战略旨在减少全球视力损失和失明的负担.